Celldextherapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celldextherapeutics

CLDX 26.76

+0.6%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: tuck	11/16/2014 1:30:29 PM
	Read Replies (1) of 5

Have followed this lately, and parsed data from the SNO confab a couple of days ago. Results look good on the surface, but check out the "patient characteristics" slide from the presentation. Hat tip to jq1234: SNO slide "patient characteristics" Time from diagnosis, relapse (much higher % of twice relapsed patients in control arm), & surgery after relapse, all skew results in favor of combo. Results are equivocal, which explains the equivocal share price reaction Friday. Don't own any, and am taking it off my watchlist. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext